alanine has been researched along with Complication, Postoperative in 17 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
Excerpt | Relevance | Reference |
---|---|---|
"Intravenous infusion of L-glutamic acid results in the augmentation of the cardiac output and an improvement of the circulation in patients with postoperative cardiac failure." | 7.67 | Cardiac metabolism and performance during L-glutamic acid infusion in postoperative cardiac failure. ( Ivanov, VE; Lepilin, MG; Pisarenko, OI, 1986) |
"In this prospective, randomized, multicenter, open-label, and comparative study, patients who had undergone ESD for EGC or gastric adenoma were randomized into groups receiving either rabeprazole monotherapy (10 mg/day, n=64) or a combination of rabeprazole plus rebamipide (300 mg/day, n=66)." | 5.22 | Limited Effect of Rebamipide in Addition to Proton Pump Inhibitor (PPI) in the Treatment of Post-Endoscopic Submucosal Dissection Gastric Ulcers: A Randomized Controlled Trial Comparing PPI Plus Rebamipide Combination Therapy with PPI Monotherapy. ( Akahoshi, K; Akiho, H; Aso, A; Harada, N; Iboshi, Y; Ihara, E; Iwasa, T; Nakamura, K; Nakamura, N; Ochiai, T; Ogino, H; Takayanagi, R, 2016) |
"The effects of postoperative infusion of a hypertonic glucose solution on the blood glucose level, blood ketone body ratio (acetoacetate/beta-hydroxybutyrate), and plasma alanine and proline levels were studied in 70% hepatectomized rabbits (group A) and in rabbits 70% hepatectomized and, in addition, subjected to bile duct obstruction at 12 h after hepatectomy (group B)." | 3.67 | Changes in blood glucose levels in relation to blood ketone body ratio following hypertonic glucose infusion in 70% hepatectomized rabbits. ( Nakatani, T; Ozawa, K; Tobe, T; Yasuda, K, 1984) |
"Intravenous infusion of L-glutamic acid results in the augmentation of the cardiac output and an improvement of the circulation in patients with postoperative cardiac failure." | 3.67 | Cardiac metabolism and performance during L-glutamic acid infusion in postoperative cardiac failure. ( Ivanov, VE; Lepilin, MG; Pisarenko, OI, 1986) |
"This study enrolled 60 eyes of 30 dry eye patients undergoing corneal refractive surgery." | 2.80 | Effect of Rebamipide Ophthalmic Suspension on Intraocular Light Scattering for Dry Eye After Corneal Refractive Surgery. ( Igarashi, A; Kamiya, K; Kobashi, H; Shimizu, K, 2015) |
" We conclude that the duration and dosage of glutamine administration (equivalent to 26 gm glutamine per day in a patient weighing 70 kg) used in this study are not sufficient to restore glutamine deficiency of the skeletal muscle in the depleted state." | 1.28 | Glutamine-containing dipeptides as infusion substrates in the septic state. ( Fürst, P; Karner, J; Ollenschläger, G; Roth, E; Simmel, A, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (52.94) | 18.7374 |
1990's | 1 (5.88) | 18.2507 |
2000's | 2 (11.76) | 29.6817 |
2010's | 3 (17.65) | 24.3611 |
2020's | 2 (11.76) | 2.80 |
Authors | Studies |
---|---|
Ahluwalia, M | 1 |
Givertz, MM | 1 |
Mehra, MR | 1 |
Ma, R | 1 |
Zhang, Q | 1 |
Zhang, YS | 1 |
Xu, B | 1 |
Tong, ZW | 1 |
Zhao, CS | 1 |
Zhao, RG | 1 |
Faitot, F | 1 |
Ruhland, E | 1 |
Oncioiu, C | 1 |
Besch, C | 1 |
Addeo, P | 1 |
Cicek, AE | 1 |
Bachellier, P | 1 |
Namer, IJ | 1 |
Igarashi, A | 1 |
Kamiya, K | 1 |
Kobashi, H | 1 |
Shimizu, K | 1 |
Nakamura, K | 1 |
Ihara, E | 1 |
Akiho, H | 1 |
Akahoshi, K | 1 |
Harada, N | 1 |
Ochiai, T | 2 |
Nakamura, N | 1 |
Ogino, H | 1 |
Iwasa, T | 1 |
Aso, A | 1 |
Iboshi, Y | 1 |
Takayanagi, R | 1 |
Bendszus, M | 1 |
Martin-Schrader, I | 1 |
Schlake, HP | 1 |
Solymosi, L | 1 |
Nakatani, T | 1 |
Yasuda, K | 1 |
Ozawa, K | 1 |
Tobe, T | 1 |
Kingsland, PA | 1 |
Kingsnorth, A | 1 |
Royle, GT | 1 |
Kettlewell, MG | 1 |
Ross, BD | 1 |
Swaminathan, R | 1 |
Morgan, DB | 1 |
Hill, GL | 1 |
Bradley, JA | 1 |
Jacobi, CA | 1 |
Ordemann, J | 1 |
Zuckermann, H | 1 |
Döcke, W | 1 |
Volk, HD | 1 |
Müller, JM | 1 |
Kasuya, H | 1 |
Kikuchi, K | 1 |
Imamura, T | 1 |
Kawashima, A | 1 |
Aihara, Y | 1 |
Yamaguchi, K | 1 |
Fukamachi, K | 1 |
Hori, T | 1 |
Shiseki, M | 1 |
Tozuka, K | 1 |
Marchuk, JB | 1 |
Finley, RJ | 1 |
Groves, AC | 1 |
Wolfe, LI | 1 |
Holliday, RL | 1 |
Duff, JH | 1 |
Chesney, RW | 1 |
Kaplan, BS | 1 |
Freedom, RM | 1 |
Haller, JA | 1 |
Drummond, KN | 1 |
Nghiem, DD | 1 |
Conrad, GR | 1 |
Rezai, K | 1 |
Kirchner, PT | 1 |
Corry, RJ | 1 |
Kuni, CC | 1 |
du Cret, RP | 1 |
Boudreau, RJ | 1 |
Karner, J | 2 |
Roth, E | 1 |
Ollenschläger, G | 1 |
Fürst, P | 1 |
Simmel, A | 1 |
Pisarenko, OI | 1 |
Lepilin, MG | 1 |
Ivanov, VE | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Phase III Study of Metabolic Intervention With Glutamate in Coronary Surgery II[NCT02592824] | Phase 3 | 321 participants (Actual) | Interventional | 2015-11-15 | Completed | ||
Phase III Study of Intravenous Glutamate Infusion for Metabolic Protection of the Heart in Surgery for Unstable Coronary Artery Disease[NCT00489827] | Phase 3 | 865 participants (Actual) | Interventional | 2005-10-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Postoperative mortality was defined as mortality within 30 days of surgery. (NCT02592824)
Timeframe: up to 30 days
Intervention | Participants (Count of Participants) |
---|---|
Intravenous Glutamate Infusion | 1 |
Intravenous Saline Infusion | 6 |
suspected unexpected serious adverse reaction (NCT02592824)
Timeframe: within 24 hours from infusion
Intervention | Participants (Count of Participants) |
---|---|
Intravenous Glutamate Infusion | 0 |
Intravenous Saline Infusion | 0 |
"Postoperative stroke was defined as neurological or cognitive deficit with a cerebral injury verified on (Computed Tomography) CT-scan. All suspected cases of stroke underwent CT-scan.~Stroke within 24 h of surgery was defined as a stroke that occurred within 24 h of surgery or signs of a stroke, when first assessable in deeply sedated patients on a ventilator." (NCT02592824)
Timeframe: within 24 hours from surgery
Intervention | Participants (Count of Participants) |
---|---|
Intravenous Glutamate Infusion | 0 |
Intravenous Saline Infusion | 4 |
"Postoperative increase of NT-proBNP reflects postoperative myocardial dysfunction sustained in association with surgery. NT-proBNP usually peaks on the third to fourth postoperative day after coronary artery bypass surgery.~In the first GLUTAMICS trial a good agreement between hemodynamic criteria for postoperative heart failure and postoperative NT-proBNP was found." (NCT02592824)
Timeframe: from the day before surgery to the third postoperative day
Intervention | ng/L (Mean) |
---|---|
Intravenous Glutamate Infusion | 5390 |
Intravenous Saline Infusion | 6452 |
"Postoperative increase of NT-proBNP reflects postoperative myocardial dysfunction sustained in association with surgery. NT-proBNP usually peaks on the third to fourth postoperative day after coronary artery bypass surgery.~Previous observations suggest a blunted effect of glutamate in diabetic hearts." (NCT02592824)
Timeframe: from preoperative level to the third postoperative day
Intervention | ng/L (Mean) |
---|---|
Intravenous Glutamate Infusion | 4503 |
Intravenous Saline Infusion | 6825 |
Postoperative NT-proBNP reflects postoperative myocardial dysfunction. (NCT02592824)
Timeframe: first postoperative day
Intervention | ng/L (Mean) |
---|---|
Intravenous Glutamate Infusion | 4438 |
Intravenous Saline Infusion | 4420 |
Postoperative NT-proBNP reflects postoperative myocardial dysfunction. (NCT02592824)
Timeframe: third postoperative day
Intervention | ng/L (Mean) |
---|---|
Intravenous Glutamate Infusion | 8055 |
Intravenous Saline Infusion | 8804 |
Number of patients with atrial fibrillation recorded postoperatively (NCT00489827)
Timeframe: Hospital stay
Intervention | Participants (Count of Participants) |
---|---|
Intravenous Glutamate | 147 |
Saline Infusion | 152 |
ICU duration of stay (hours) (NCT00489827)
Timeframe: ICU stay
Intervention | hours (Median) |
---|---|
Intravenous Glutamate | 21 |
Saline Infusion | 21 |
(NCT00489827)
Timeframe: 30 days
Intervention | Participants (Count of Participants) |
---|---|
Intravenous Glutamate | 31 |
Saline Infusion | 25 |
Incidence of Postoperative stroke < 24 hours of surgery verifed by CT-scan (NCT00489827)
Timeframe: 24 hours
Intervention | Participants (Count of Participants) |
---|---|
Intravenous Glutamate | 4 |
Saline Infusion | 6 |
Hemodynamic instability despite inotropes or need for IABP at the end of surgery in patients with severely reduced left ventricular ejection fraction (LVEF<0.40) (NCT00489827)
Timeframe: End of surgery
Intervention | Participants (Count of Participants) |
---|---|
Intravenous Glutamate | 1 |
Saline Infusion | 5 |
maximum p-creatinine value recorded postoperatively < 30 days (NCT00489827)
Timeframe: 30 days
Intervention | µmol/L (Mean) |
---|---|
Intravenous Glutamate | 106 |
Saline Infusion | 106 |
Severe circulatory failure according to prespecified criteria as judged by a blinded endpoints committee in CCS class IV patients (NCT00489827)
Timeframe: 30 days
Intervention | Participants (Count of Participants) |
---|---|
Intravenous Glutamate | 3 |
Saline Infusion | 16 |
p-CK-MB postoperative day 1, p-troponin-T postoperative day 3 (NCT00489827)
Timeframe: perioperative
Intervention | µg/L (Median) | |
---|---|---|
CK-MB day 1 | Troponin-T day 3 | |
Intravenous Glutamate | 14 | 0.27 |
Saline Infusion | 14 | 0.24 |
Mixed venous oxygen saturation (SvO2) measured at weaning from cardiopulmonary bypass and on arrival to ICU (NCT00489827)
Timeframe: Until arrival to ICU
Intervention | percentage of saturated hemoglobin (Mean) | |
---|---|---|
SvO2 at weaning from CPB | SvO2 on arrival to ICU | |
Intravenous Glutamate | 72.0 | 65.0 |
Saline Infusion | 72.2 | 64.9 |
3 trials available for alanine and Complication, Postoperative
Article | Year |
---|---|
Effect of Rebamipide Ophthalmic Suspension on Intraocular Light Scattering for Dry Eye After Corneal Refractive Surgery.
Topics: Administration, Topical; Adult; Alanine; Anti-Ulcer Agents; Dry Eye Syndromes; Female; Humans; Kerat | 2015 |
Limited Effect of Rebamipide in Addition to Proton Pump Inhibitor (PPI) in the Treatment of Post-Endoscopic Submucosal Dissection Gastric Ulcers: A Randomized Controlled Trial Comparing PPI Plus Rebamipide Combination Therapy with PPI Monotherapy.
Topics: Adenoma; Aged; Alanine; Anti-Ulcer Agents; Drug Therapy, Combination; Endoscopic Mucosal Resection; | 2016 |
[Effect of alanyl-glutamine in postoperative total parenteral nutrition on postoperative immunosuppression and morbidity. Preliminary results of a prospective randomized study].
Topics: Adult; Aged; Alanine; Dipeptides; Esophageal Diseases; Female; Glutamine; Humans; Immune Tolerance; | 1998 |
14 other studies available for alanine and Complication, Postoperative
Article | Year |
---|---|
A proposed strategy for management of immunosuppression in heart transplant patients with COVID-19.
Topics: Adenosine Monophosphate; Adult; Alanine; Algorithms; Antiviral Agents; Clinical Decision-Making; COV | 2020 |
Preoperative rapid suppression of viral load by elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide regimen in human immunodeficiency virus-positive fracture patients significantly reduces postoperative complications.
Topics: Adenine; Alanine; Anti-HIV Agents; Cobicistat; Drug Combinations; Emtricitabine; HIV; HIV Infections | 2020 |
Metabolomic profiling highlights the metabolic bases of acute-on-chronic and post-hepatectomy liver failure.
Topics: Acute-On-Chronic Liver Failure; Aged; Alanine; Biomarkers; Carcinoma, Hepatocellular; Female; Follow | 2019 |
Embolisation of intracranial meningiomas without subsequent surgery.
Topics: Adolescent; Adult; Aged; Alanine; Angiography; Child; Choline; Creatine; Embolization, Therapeutic; | 2003 |
Changes in blood glucose levels in relation to blood ketone body ratio following hypertonic glucose infusion in 70% hepatectomized rabbits.
Topics: Alanine; Animals; Bilirubin; Blood Glucose; Cholestasis; Citric Acid Cycle; Glucose; Glucose Solutio | 1984 |
Glutamate metabolism in malnutrition and sepsis in man.
Topics: Adult; Aged; Alanine; Bacterial Infections; Blood Glucose; Glutamates; Half-Life; Humans; Insulin; M | 1981 |
Blood concentration and disappearance of injected alanine and beta-hydroxybutyrate in surgical patients.
Topics: 3-Hydroxybutyric Acid; Alanine; Fasting; Humans; Hydroxybutyrates; Ketone Bodies; Kinetics; Postoper | 1981 |
[Two cases of methicillin-resistant Staphylococcus aureus (MRSA) sepsis following craniotomy].
Topics: Adult; Aged; Alanine; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Craniotomy; Dibekacin; Dru | 2000 |
Catabolic hormones and substrate patterns in septic patients.
Topics: Adult; Alanine; Bacterial Infections; Blood Glucose; Catecholamines; Glucagon; Humans; Insulin; Male | 1977 |
Acute renal failure: an important complication of cardiac surgery in infants.
Topics: Acute Kidney Injury; Alanine; Cardiac Surgical Procedures; Female; Heart Defects, Congenital; Humans | 1975 |
Diagnosis of pancreatic rejection with Tc-99m DTPA scintigraphy.
Topics: Alanine; beta-Alanine; Graft Rejection; Humans; Organometallic Compounds; Organotechnetium Compounds | 1989 |
Pancreas transplants: evaluation using perfusion scintigraphy.
Topics: Adult; Alanine; beta-Alanine; Female; Graft Rejection; Humans; Male; Middle Aged; Organometallic Com | 1989 |
Glutamine-containing dipeptides as infusion substrates in the septic state.
Topics: Alanine; Amino Acids; Animals; Dipeptides; Dogs; Evaluation Studies as Topic; Fasting; Female; Gluta | 1989 |
Cardiac metabolism and performance during L-glutamic acid infusion in postoperative cardiac failure.
Topics: Alanine; Ammonia; Cardiac Output; Glutamates; Glutamic Acid; Glutamine; Heart; Heart Failure; Hemody | 1986 |
Cardiac metabolism and performance during L-glutamic acid infusion in postoperative cardiac failure.
Topics: Alanine; Ammonia; Cardiac Output; Glutamates; Glutamic Acid; Glutamine; Heart; Heart Failure; Hemody | 1986 |
Cardiac metabolism and performance during L-glutamic acid infusion in postoperative cardiac failure.
Topics: Alanine; Ammonia; Cardiac Output; Glutamates; Glutamic Acid; Glutamine; Heart; Heart Failure; Hemody | 1986 |
Cardiac metabolism and performance during L-glutamic acid infusion in postoperative cardiac failure.
Topics: Alanine; Ammonia; Cardiac Output; Glutamates; Glutamic Acid; Glutamine; Heart; Heart Failure; Hemody | 1986 |